Back to Markets
AVAnavex Life Sciences Corp

Anavex Life Sciences Corp

AVXLNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$3.03

+0.0900 (+3.06%)

As of 05/29/26 EDT · USD

Compare
Low: $2.61Current: $3.03High: $13.99

Key Statistics

Open

$2.95

Day High

$3.04

Day Low

$2.81

Prev. Close

$2.94

VolumeShares traded today.

1.30M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$280.80M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-6.52

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$13.99

52W LowLowest price over the past 52 weeks.

$2.61

50D MAAverage closing price over the last 50 trading days.

$3.20

200D MAAverage closing price over the last 200 trading days.

$5.50

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+11.8%

1M

-7.1%

6M

-12.4%

YTD

-17.7%

1Y

-59.8%

About

ANAVEX 1-41, or ANAVEX1-41, is an experimental drug which is or was under development for the treatment of depressive disorders, neurodegenerative disorders, and stroke. It is a sigma σ1 receptor agonist, non-selective muscarinic acetylcholine receptor modulator, and sodium and chloride channel modulator. The drug is a positional isomer of blarcamesine and has similar actions. It was under development by Anavex Life Sciences. ANAVEX 1-41 reached the preclinical research stage of development prior to no recent development being reported as of 2022. It was intended as a backup compound for blarcamesine. The drug was first described in the scientific literature by 2007.

www.anavex.com

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade AVXL

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.